drugset / Trial / NCT06166992
A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The main objective of this trial is to investigate the absolute bioavailability of BI 1291583 (test treatment T, not radio-labelled) compared with BI 1291583 (C-14) (reference treatment R).
Timeline
- Start
- 2023-12-12
- Primary completion
- 2024-02-07
- Completion
- 2024-02-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1291583 | Unknown | — | — |
Indications
No indication recorded.